Physician profile
John S Appleton
NPI 1588714661
$17,198.77
in general payments reported to CMS, 2019-2025
27 companies · $5,461 in 2025
The $5,461 reported for 2025 was more than what 83% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,620 · 2020: $1,091 · 2021: $3,674 · 2022: $775 · 2023: $1,207 · 2024: $371 · 2025: $5,461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,500 · Royalty Or License: $1,753 · Food and Beverage: $787.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,500.00 |
| Royalty Or License | $1,752.70 |
| Food and Beverage | $786.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Total Joint Orthopedics, INC. | $14,768.28 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $608.96 | 2019-2022 | |
| Orthalign INC | $326.97 | 2019-2021 | |
| Stryker Corporation | $252.25 | 2019-2023 | Tritanium |
| Horizon Therapeutics Plc | $221.12 | 2019-2022 | |
| Bioventus LLC | $176.59 | 2023-2025 | Durolane, Exogen Ultrasound Bone Healing System, Durolane |
| Innovation Technologies INC | $118.05 | 2023-2025 | Irrisept |
| Pacira Therapeutics, INC. | $86.43 | 2019 | |
| Depuy Synthes Sales INC. | $85.56 | 2020-2024 | Monovisc, Orthovisc |
| Ethicon US, LLC | $80.19 | 2022-2024 | Vistaseal, Stratafix |
| Kinamed, INC. | $70.00 | 2023 | |
| Ferring Pharmaceuticals INC. | $55.07 | 2019-2022 | |
| Heraeus Medical, LLC. | $37.30 | 2021 | |
| Integra Lifesciences Corporation | $36.80 | 2022 | |
| Kci USA, INC. | $33.09 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $29.47 | 2021 | |
| Smith+Nephew, INC. | $27.37 | 2019-2025 | Stravix |
| Orthofix Medical, INC. | $23.81 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $22.77 | 2019 | |
| Ermi LLC | $21.45 | 2019 | |
| Molnlycke Health Care US, LLC | $21.32 | 2024 | Avance, Mepilex Border Post-Op Ag |
| Wright Medical Technology, INC. | $20.38 | 2020 | |
| Dynasplint Systems INC. | $17.76 | 2019 | |
| Becton, Dickinson and Company | $15.88 | 2022 | |
| Medical Device Business Services, INC. | $14.93 | 2021 | |
| Ossur Americas, INC. | $13.50 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $13.47 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Appleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.